Australian Clinical Labs Ltd (AU:ACL) has released an update.
Citigroup Global Markets Australia Pty Limited and its affiliates, which constitute substantial shareholders of Australian Clinical Labs Ltd, have experienced a change in their holdings. The group’s voting power has decreased from 8.0943% to 6.7891%, following various securities transactions, including securities lending agreements and stock market activities. These changes occurred on September 2, 2024, as detailed in the company’s latest filing.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
